In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.


The free consultation period for this content is over.

It is now only available year-round to ACNAP Silver Members, Fellows of the ESC and Young combined Members

Physical activity after cardiac arrest; a description of a sub-study in the Target Temperature Management Trial 2.

Session Poster Session 1

Speaker Katarina Heimburg

Congress : EuroHeartCare 2019

  • Topic : preventive cardiology
  • Sub-topic : Cardiovascular Rehabilitation
  • Session type : Poster Session
  • FP Number : P128

Authors : K Heimburg (Lund,SE), T Cronberg (Lund,SE), A Tornberg (Lund,SE), H Friberg (Lund,SE), N Nielsen (Helsingborg,SE), G Lilja (Lund,SE)

Authors:
K Heimburg1 , T Cronberg2 , A Tornberg3 , H Friberg4 , N Nielsen5 , G Lilja2 , 1Lund University, Skane University Hospital, Department of Clinical Sciences, Cardiology - Lund - Sweden , 2Lund University, Skane University Hospital, Department of Clinical Sciences, Neurology - Lund - Sweden , 3Lund University, Department of Health Sciences - Lund - Sweden , 4Lund University, Skane University Hospital, Department of Clinical Sciences, Anesthesia and Intensive Care - Lund - Sweden , 5Lund University, Hospital of Helsingborg, Deparment of Clinical Sciences, Anesthesiology and Intensive Care - Helsingborg - Sweden ,

On behalf: Center for cardiac arrest, Lund University Sweden

Citation:

Coronary artery disease (CAD) is the most common cause of Out-of-Hospital Cardiac Arrest (OHCA), and a major risk factors for CAD is physical inactivity. Physical exercise is an established preventive strategy for CAD, and has become an important part of cardiac rehabilitation programs. OHCA-survivors may have difficulties to obtain enough physical activity for secondary prevention due to cognitive and emotional problems. Currently there are no studies that have investigated physical activity in OHCA-survivors.

The aims:

1, To investigate whether OHCA-survivors have lower levels of self-reported physical activity compared to a non-cardiac arrest control group of myocardial infarction (MI) patients, and explore the association to selected variables assumed important for decreased physical activity.

2, To investigate the relationship between self-reported and objectively measured physical activity among OHCA-survivors.

This study will be performed as a sub-study of the TTM2-trial, where all OHCA-survivors are invited to a structured face-to-face follow-up 6-months post-OHCA. At time of this follow-up the OHCA-survivors are informed about this sub-study, and for those who consent to participate a second follow-up will take part within 4 weeks. The included OHCA-survivors will be provided a hip-placed accelerometer to wear for one week. After this week they will answer two self-reported questions about physical activity. Information regarding variables of assumed importance for physical activity will be collected. A control group of myocardial infarction patients will be included in 1:1 ratio and perform the same follow-up except for wearing the Actigraph. The first TTM2-patient was included in November 2017, and the first sub-study patient in July 2018.

The results from this sub-study will provide important information of OHCA-survivors physical activity, and how to measure it among OHCA survivors.

The free consultation period for this content is over.

It is now only available year-round to ACNAP Silver Members, Fellows of the ESC and Young combined Members



Based on your interests

Members get more

Join now
  • 1ESC Professional Members – access all resources from ESC Congress and ESC Asia with APSC & AFC
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s congress resources
  • 3Under 40 or in training - with a Combined Membership, access resources from all congresses
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are